epafenac 0.1 Eye Drops, Suspension compared to Ketorolac Trometamol 0.5 Eye Drops, Solution and Placebo Nepafenac Vehicle for the Prevention and Treatment of Ocular Inflammation and Ocular pain associated with Cataract Surgery European Study.
- Conditions
- MedDRA version: 6.1Level: PTClassification code 10015943non steroidal anti inflammatory drug for prophylaxix and teraphy of ocular inflammation and ocular pain after cataract surgery.
- Registration Number
- EUCTR2005-002647-35-IT
- Lead Sponsor
- ALCON ITALIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method